Fact CheckerSign in

NCT06973499Completed

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

Source: ClinicalTrials.gov · Last updated 15 May 2025

Brief summary (registry, in English)

This is an exploratory, single-center, being conducted at Beijing Haidian Hospital in order to detect the relationship between microbiome of upper gastrointestinal and pathogenesis of multiple primary lung cancer.

Status (registry)
Completed
Study type
Observational
Enrollment
20 (actual)
First submitted
25 Jun 2022
Start date
6 Jan 2023
Primary completion date
30 May 2024
Lead sponsor
Beijing Haidian Hospital
Diseases
Lung cancer
NCT number
NCT06973499

What you commit to

  • Study type: Observational
  • Participants enrolled: 20
  • From 6 Jan 2023 to the primary completion date, 30 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Preoperative examination of patients who cannot tolerate surgical resection
  • Patients who received antibiotics within 1 week before surgery E) Resected multiple pulmonary nodules with pathologically proven lung cancer of less than 2 patients

Other illness

  • severe heart, liver, brain, kidney and other important organ diseases and bone marrow hematopoietic dysfunction;
  • Multiple nodules resected were confirmed to be metastases, not primary lung cancer

Age

  • under 18 years of age (excluding 18 years of age, male or female) or unwilling to sign informed consent;

Who the study is looking for

  • At least 18 years of age (including 18 years of age, male or female) and voluntarily signed informed consent;
  • Chest CT imaging showed at least 2 pulmonary nodules with a diameter of less than 3cm in ipsilateral lung, and imaging diagnosis of highly suspicious multiple primary lung cancer
  • No surgical contraindication, surgical resection is feasible, and postoperative pathology is diagnosed as multiple primary lung cancer according to Martini and Melamed criteria and gene testing
  • The amount of at least 2 or more tissues removed from multiple pulmonary nodules must meet the requirements of pathological diagnosis, molecular detection and microflora detection

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Haidian Hospital
Coordinator of this site? Confirm its status
BeijingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.